Alnylam Pharma's total assets for Q1 2025 were $4.21B, a decrease of -2.05% from the previous quarter. ALNY total liabilities were $4.10B for the fiscal quarter, a -1.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.